BioCorRx Inc. Files 2024 10-K, Reports Assets and Liabilities
Ticker: BICX · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1443863
| Field | Detail |
|---|---|
| Company | Biocorrx Inc. (BICX) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financials, 10-K, assets, liabilities
TL;DR
BioCorRx 2024 10-K filed: $13.3M assets, $8.7M liabilities. Warrants issued March 2025.
AI Summary
BioCorRx Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company reported total assets of $13,299,349 and total liabilities of $8,674,029. Significant events include the issuance of warrants in March 2025 and the company's operations in specialty outpatient facilities.
Why It Matters
This filing provides a year-end financial snapshot of BioCorRx Inc., detailing its assets and liabilities, which is crucial for investors and stakeholders to assess the company's financial health and performance.
Risk Assessment
Risk Level: medium — The company's financial statements show a significant portion of liabilities relative to assets, and the nature of its business in specialty outpatient facilities can be subject to regulatory and market risks.
Key Numbers
- $13.3M — Total Assets (As of December 31, 2024)
- $8.7M — Total Liabilities (As of December 31, 2024)
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
Key Players & Entities
- BioCorRx Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- $13,299,349 (dollar_amount) — Total assets
- $8,674,029 (dollar_amount) — Total liabilities
- March 2025 (date) — Warrant issuance date
FAQ
What was BioCorRx Inc.'s net income or loss for the fiscal year ended December 31, 2024?
The provided text does not explicitly state the net income or loss for the fiscal year ended December 31, 2024. It focuses on balance sheet items like total assets and liabilities.
What is the nature of BioCorRx Inc.'s business operations?
BioCorRx Inc. operates in the 'SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC' sector, with SIC code 8093.
When were warrants issued by BioCorRx Inc. as a subsequent event?
Warrants were issued as a subsequent event in March 2025.
What were the total assets and liabilities of BioCorRx Inc. as of December 31, 2024?
As of December 31, 2024, BioCorRx Inc. reported total assets of $13,299,349 and total liabilities of $8,674,029.
What is the company's principal executive office address?
The company's business and mail address is 2390 East Orangewood Avenue, Suite 570, Anaheim, CA 92806.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding BioCorRx Inc. (BICX).